Citicoline Tablets

Description

Citicoline Tablets (500mg / 1000mg)

Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. is a specialized manufacturer of Citicoline Sodium Tablets in India. Citicoline (CDP-choline) is a precursor involved in phospholipid and acetylcholine metabolism and is marketed as a neurological or nootropic agent in a number of countries. Approved indications vary by jurisdiction. We offer contract manufacturing services for conventional and controlled-release presentations, while Healthy Inc manages international export logistics.

2. Product Specifications

3. Manufacturing Technology

• Moisture Control: Citicoline formulations can require careful humidity control. Manufacturing and packaging conditions are selected according to validated product and stability requirements.
• Controlled Release: For controlled-release presentations, release-controlling excipients and process parameters are validated to achieve the registered dissolution profile.
• High-Dose Compaction: Excipient selection, blending and compression are optimized to maintain tablet integrity and dosage-unit uniformity at higher strengths.
• Packaging: High-barrier packaging such as Alu-Alu may be used where supported by stability data.

4. Quality Assurance

• Assay & Content Uniformity: Potency and dosage-unit uniformity are verified against approved specifications.
• Dissolution / Release Profile: Conventional or controlled-release presentations are tested using the applicable validated method.
• Related Substances: Relevant degradation products are monitored during batch release and stability studies.
• Moisture: Moisture-related quality attributes are controlled where applicable to the registered formulation.

5. Citicoline Pharmacology

Citicoline is metabolized to cytidine and choline and participates in pathways involved in phosphatidylcholine synthesis and cholinergic neurotransmission. It has been investigated in a range of neurological and cognitive conditions, but the strength of evidence and approved therapeutic uses differ between countries and indications.

Clinical Use Considerations:

• Cognitive Symptoms: Citicoline is used or marketed for selected cognitive indications in some jurisdictions; use should follow locally approved labeling.
• Stroke / Neurological Recovery: Citicoline has been studied in stroke and other neurological conditions, but it should not be described as a substitute for evidence-based acute stroke treatment or rehabilitation.
• Traumatic Brain Injury: Evidence has been studied in TBI, but routine treatment claims should follow current local guidance and registered indications.
• Healthy-User Cognitive Enhancement: This product information does not recommend prescription-strength Citicoline for unsupervised “smart drug” use by healthy individuals.

6. Export and Regulatory Support

• Dossier Support: CTD and ACTD documentation where applicable.
• Certificates: FSC, COPP and COA where applicable.
• Logistics: Air or sea shipment via FOB Mumbai / CIF according to regulatory and commercial requirements.

7. Frequently Asked Questions

Q: Who manufactures Citicoline Tablets?
A: Healthy Life Pharma Pvt. Ltd. manufactures Citicoline tablet formulations in India.

Q: Is Citicoline sold under different brand names?
A: Yes. Citicoline is marketed under various brands internationally. Generic equivalence and interchangeability depend on the registered formulation and local regulatory requirements.

Q: Is Citicoline a stimulant?
A: Citicoline is not an amphetamine-type stimulant. It affects pathways involved in phospholipid and neurotransmitter metabolism; its approved classification and uses vary by market.

Q: Can healthy people take Citicoline just to improve focus or memory?
A: Routine unsupervised use for cognitive enhancement is not recommended by this product information. Patients should follow local labeling and healthcare-professional advice.

Clinical Pharmacology & Safety Information

(For Registered Medical Practitioners & Patient Reference)

8. Dosage and Administration

• Dose: Dosage and duration depend on the registered indication, formulation and individual clinical assessment.
• Controlled Release Tablets: Swallow whole unless the approved product information specifically permits splitting or crushing; altering a controlled-release tablet can change drug release.
• Administration: Follow the prescribed schedule and the instructions for the specific registered product.

9. Side Effects and Precautions

• Gastrointestinal: Nausea, abdominal discomfort or diarrhea may occur.
• CNS: Headache, dizziness, restlessness or sleep disturbance may occur in some patients.
• Cardiovascular: Changes in blood pressure or heart rate have been reported; clinically significant symptoms require medical assessment.
• Pregnancy / Breastfeeding: Use should be based on medical assessment because safety information may be limited for specific products and indications.
• Drug Interactions: Patients should provide clinicians with a complete medicine list before starting treatment.

10. Storage Instructions

• Store below 25°C in a dry place.
• Protect from moisture and excessive heat.
• Keep in the original blister or packaging until use.
• Keep out of reach of children.